Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
Clinical trial NCT04216342 · RECRUITING
Trial details
- NCT number
- NCT04216342
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-29
- Primary completion
- 2027-06-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.